You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 121 No. 6, June 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Epidemiology
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (8)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Articles for Residents
 •Glaucoma
 •Alert me on articles by topic

Factors Related to the 4-Year Risk of High Intraocular Pressure

The Barbados Eye Studies

Barbara Nemesure, PhD; Suh-Yuh Wu, MA; Anselm Hennis, MRCP(UK), PhD; M. Cristina Leske, MD, MPH; for the Barbados Eye Studies Group

Arch Ophthalmol. 2003;121:856-862.

Objective  To evaluate the 4-year risk of high intraocular pressure (IOP) and associated factors in a black population without glaucoma at baseline.

Design  Population-based incidence study.

Participants  Random sample of Barbados residents aged 40 to 84 years. After 4 years, 3427 (85%) were reexamined.

Main Outcome Measures  Development of elevated IOP (using percentile-based definitions) among individuals with an IOP of 21 mm Hg or lower and no glaucoma at baseline. Associations were evaluated using polychotomous logistic regression.

Results  At baseline, 2856 participants did not have glaucoma or suspected glaucoma: 361 had an IOP higher than 21 mm Hg or received treatment, and 2495 had an IOP of 21 mm Hg or lower and no treatment. At follow-up, only 58% of the 361 participants remained free of glaucoma and had an IOP higher than 21 mm Hg, whereas 30% had an IOP of 21 mm Hg or lower. Among the remaining 2495 participants, the incidence of IOP higher than 21 mm Hg or treatment (80th percentile) was 12.9% (95% confidence interval, 11.7%-14.3%). Using other definitions of elevated IOP, estimates ranged from 1.5% to 11%. Incidence increased with age, with rates 2.5 times higher at 70 years or older than at ages 40 to 49 years. Factors associated with high IOP included age, baseline IOP, hypertension, and blood pressure. Whereas participants with an IOP between 21 mm Hg and 28 mm Hg had higher blood pressure readings, those with an IOP of 21 mm Hg or lower or an IOP higher than 28 mm Hg had similar values.

Conclusions  Definitions of high IOP based on percentiles may be more applicable than those based on arbitrary values. Older individuals with a higher baseline IOP were more likely to develop elevated IOP after 4 years. Although blood pressure was also associated with high IOP, the relationship may be nonlinear.


From the School of Medicine, Stony Brook University, Stony Brook, NY (Drs Nemesure, Hennis, and Leske and Ms Wu); Ministry of Health, Bridgetown, Barbados (Dr Hennis); and School of Clinical Medicine and Research, University of the West Indies, Bridgetown (Dr Hennis). Drs Nemesure, Hennis, and Leske and Ms Wu have no relevant financial interest in this article.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Open-angle Glaucoma and Mortality: The Barbados Eye Studies
Wu et al.
Arch Ophthalmol 2008;126:365-370.
ABSTRACT | FULL TEXT  

Socioeconomic status, systolic blood pressure and intraocular pressure: the Tanjong Pagar Study
Yip et al.
Br. J. Ophthalmol. 2007;91:56-61.
ABSTRACT | FULL TEXT  

Nine-year changes in intraocular pressure: the barbados eye studies.
Wu et al.
Arch Ophthalmol 2006;124:1631-1636.
ABSTRACT | FULL TEXT  

Genomewide scan and fine mapping of quantitative trait Loci for intraocular pressure on 5q and 14q in west africans.
Rotimi et al.
IOVS 2006;47:3262-3267.
ABSTRACT | FULL TEXT  

Early Adult-Onset POAG Linked to 15q11-13 Using Ordered Subset Analysis
Allingham et al.
IOVS 2005;46:2002-2005.
ABSTRACT | FULL TEXT  

Intraocular pressure in the Middle East
Hennis
Br. J. Ophthalmol. 2005;89:647-648.
FULL TEXT  

Glaucoma and its treatment: A review
Lee and Higginbotham
Am J Health Syst Pharm 2005;62:691-699.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.